These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of multiple sclerosis]. Midgard R Tidsskr Nor Laegeforen; 2001 Aug; 121(19):2254. PubMed ID: 11571873 [No Abstract] [Full Text] [Related]
3. Magnetic resonance imaging as an outcome measure in the treatment of multiple sclerosis: results of the interferon beta trial. Koopmans RA; Paty DW Mult Scler; 1995; 1 Suppl 1():S22-3. PubMed ID: 9345393 [No Abstract] [Full Text] [Related]
5. [10 years of interferon treatment in multiple sclerosis. Does the future belong to high-dose therapy?]. MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579501 [No Abstract] [Full Text] [Related]
6. [High doses of interferon in the treatment of multiple sclerosis]. Muñoz D Rev Neurol; 2001 May 1-15; 32(9):899. PubMed ID: 11424041 [No Abstract] [Full Text] [Related]
7. [About the article: "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis" by Jacobs LD et al]. Labetouelle M J Fr Ophtalmol; 2001 Feb; 24(2):222. PubMed ID: 11332406 [No Abstract] [Full Text] [Related]
8. Erythema elevatum et diutinum, multiple sclerosis and interferon beta. Gil M; Chizzolini C; Kaya G; Hauser C Dermatology; 2004; 209(1):75-6. PubMed ID: 15237277 [No Abstract] [Full Text] [Related]
9. Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a. Almeida L; Neves M; Cardoso E; Melo A J Clin Pharm Ther; 2009 Feb; 34(1):125-7. PubMed ID: 19125911 [TBL] [Abstract][Full Text] [Related]
11. Combination therapy for treatment of multiple sclerosis. Lublin FD; Reingold SC Ann Neurol; 1998 Jul; 44(1):7-9. PubMed ID: 9667587 [No Abstract] [Full Text] [Related]
12. A rare 'palisading' enhancing pattern of multiple sclerosis. Huang CF; Lo CP; Tseng CY; Chen YC Eur Neurol; 2012; 67(3):161. PubMed ID: 22261728 [No Abstract] [Full Text] [Related]
13. [Nursing service for MS patients]. Krankenpfl J; 2005; 43(7-10):235. PubMed ID: 16518890 [No Abstract] [Full Text] [Related]
14. Treatment of relapsing-remitting multiple sclerosis with natural interferon beta: a multicenter, randomized clinical trial. Fernández O; Antiquëdad A; Arbizu T; Capdevíla A; de Castro P; Correa de Sa JC; García-Merino JA; Izquierdo G; Magalhaes A; Montalbán X Mult Scler; 1995; 1 Suppl 1():S67-9. PubMed ID: 9345404 [TBL] [Abstract][Full Text] [Related]
15. Approaches to neuroprotective strategies in multiple sclerosis. Tselis A; Khan OA; Lisak RP Expert Opin Pharmacother; 2010 Dec; 11(17):2869-78. PubMed ID: 20687779 [TBL] [Abstract][Full Text] [Related]
16. Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trial. Polman CH; Dahlke F; Thompson AJ; Ghazi M; Kappos L; Miltenburger C; Pozilli C Mult Scler; 1995; 1 Suppl 1():S51-4. PubMed ID: 9345400 [TBL] [Abstract][Full Text] [Related]
17. [Association of multiple sclerosis and autoimmune thrombopenia]. Granier H; Bellard S; Nicolas X; Laborde JP; Talarmin F Rev Med Interne; 2001 Dec; 22(12):1271-2. PubMed ID: 11794901 [No Abstract] [Full Text] [Related]
18. [Eucharist bacteria brought miserey--bilateral parotitis led to emergency tracheotomy]. Wölk G; Zehlicke T; Pohl M Laryngorhinootologie; 2012 May; 91(5):321-2. PubMed ID: 22311199 [No Abstract] [Full Text] [Related]
19. The use of interferon beta at the time of initial diagnosis of multiple sclerosis. Pender MP J Clin Neurosci; 2001 Jul; 8(4):381-2. PubMed ID: 11437589 [No Abstract] [Full Text] [Related]